Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Risk Management Programs May Become Routine Element In FDA Reviews

Executive Summary

The establishment of "risk management" programs for pharmaceuticals may become a routine part of the FDA approval process.

You may also be interested in...



FDA To Study "Labeling Fatigue": Do Serial Changes Influence Prescribing?

FDA is planning an internal research effort to examine the concept of "labeling fatigue," which suggests that serial label changes or extensive warnings in the package insert have limited ability to alter prescribing behavior.

FDA To Study "Labeling Fatigue": Do Serial Changes Influence Prescribing?

FDA is planning an internal research effort to examine the concept of "labeling fatigue," which suggests that serial label changes or extensive warnings in the package insert have limited ability to alter prescribing behavior.

Glaxo's Lotronex Risk-Management Program Emphasizes Appropriate Use

Glaxo Wellcome is proposing an "appropriate use" campaign as the focus of its risk-management plan for Lotronex, the company told FDA's Gastrointestinal Drugs Advisory Committee June 27.

Related Content

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel